✦ LIBER ✦

Oral leukoplakia in China: a review

✍ Scribed by Xiaolin Zhang; Chengjie Li; Yi Song; Peter A. Reichart

Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 172 KB
Volume: 14
Category: Article
ISSN: 1865-1550
DOI: 10.1007/s10006-010-0214-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Leukoplakia revisited. A clinicopatholog

Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias

✍ Charles A. Waldron; William G. Shafer 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

During a 13-year period, 3256 specimens clinically diagnosed as leukoplakia (('keratosis," "white patch") were submitted to the oral pathology laboratories of Indiana University School of Dentistry and Emory University School of Dentistry. These comprised 6.2% of the tissue Specimens processed by th

Oral Leukoplakia as a precancerous condi

Oral Leukoplakia as a precancerous condition

✍ J. J. Pindborg 📂 Article 📅 1966 🏛 Springer-Verlag 🌐 English ⚖ 65 KB

Oral manifestations of HIV/AIDS in China

Oral manifestations of HIV/AIDS in China: a review

✍ Xiaolin Zhang; Peter A. Reichart; Yi Song 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 120 KB

Laryngeal precancer: A review of the lit

Laryngeal precancer: A review of the literature, commentary, and comparison with oral leukoplakia

✍ Dr. Jerry E. Bouquot; Dr. Douglas R. Gnepp 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 926 KB

Laryngeal keratosis (LK) is a precancerous mucosal change with great similarity to oral leukoplakia. Its malignant transformation rate varies from 1% to 40%, with the highest rates being found in patients microscopically diagnosed as "keratosis with atypia" (KWA). Recent evidence indicates that even

A review of the use of antioxidant suppl

A review of the use of antioxidant supplements in the treatment of human oral leukoplakia

✍ Dr. George E. Kaugars; Sol Silverman Jr.; John G. L. Lovas; Richard B. Brandt; J 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Over the past twenty years, research into the role of antioxidants in the prevention of cancer has increased dramatically. The use of antioxidant supplements to treat oral leukoplakia has gained acceptance due to the success demonstrated in several clinical trials. This review discusses the role of

Fenretinide (4-HPR) in chemoprevention o

Fenretinide (4-HPR) in chemoprevention of oral leukoplakia

✍ Fausto Chiesa; Nicoletta Tradati; Marino Marazza; Nicoletta Rossi; Patrizia Bora 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

A controlled clinical trial has been underway at the Istituto Nazionale Tumori (INT) of Milan since 1988. The goal of the trial is to evaluate the effectiveness of fenretinide (4-HPR) in preventing relapses, new localizations, and carcinomas in patients with benign postoperative diagnoses who have b